| Literature DB >> 33241111 |
Wei Wang1,2,3, Zhao-Hui Wu1,2,3.
Abstract
Oncogenic Wnt/β-catenin activation promotes cancer development and drug resistance to cancer treatments. We recently revealed an underlying mechanism linking linear ubiquitination with Wnt/β-catenin activation upon genotoxic treatments. We showed that ABL1 (ABL proto-oncogene 1)-dependent phosphorylation of OTULIN (OTU deubiquitinase with linear linkage specificity) upon DNA damage drives β-catenin activation which promotes drug resistance in triple-negative breast cancer.Entities:
Keywords: DNA damage; OTULIN; drug resistance; linear ubiquitination; β-catenin
Year: 2020 PMID: 33241111 PMCID: PMC7671033 DOI: 10.1080/23723556.2020.1825904
Source DB: PubMed Journal: Mol Cell Oncol ISSN: 2372-3556